Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIME: MenACWY booster in adolescents primed with MenC vaccines
NCT01192997Phase 3Completed
- Sponsor
- UK Health Security Agency
- Start
- Jun 2012
- Primary completion
- Oct 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal A conjugate vaccine, meningococcal group A, C, W, and Y tetanus toxoid conjugate vaccine in meningococcal meningitis, sponsored by UK Health Security Agency. Started Jun 2012; status: completed.
02
Drugs
meningococcal A conjugate vaccinemeningococcal group A, C, W, and Y tetanus toxoid conjugate vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT01192997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01192997.